Characterizing a Clinical Trial - Representative, Real-World Population with Heart Failure with Reduced Ejection Fraction

被引：1

作者：

Wells, Quinn S. ^{[1
,2
]}

Farber-Eger, Eric ^{[1
,2
]}

Lipworth, Loren ^{[2
,3
]}

Dluzniewski, Paul ^{[4
]}

Dent, Ricardo ^{[4
]}

Umeijiego, John ^{[4
]}

Cohen, Sarah S. ^{[3
,5
]}

机构：

[1] Vanderbilt Univ, Dept Med, Div Cardiovasc Med, Med Ctr, Nashville, TN USA

[2] Vanderbilt Univ, Med Ctr, Vanderbilt Translat & Clin Cardiovasc Res Ctr VTR, Nashville, TN USA

[3] Vanderbilt Univ, Dept Med, Div Epidemiol, Med Ctr, Nashville, TN 37235 USA

[4] Amgen Inc, Ctr Observat Res, Thousand Oaks, CA 91320 USA

[5] Toxstrategies Inc, Epidstrategies, Cary, NC 27511 USA

来源：

CLINICAL EPIDEMIOLOGY | 2022年 / 14卷

关键词：

heart failure; reduced ejection fraction; real-world evidence; electronic health record; RANDOMIZED INTERVENTION TRIAL; CIBIS-II; MORTALITY; ENALAPRIL; SURVIVAL; METOPROLOL; MORBIDITY; OUTCOMES;

D O I：

10.2147/CLEP.S341919

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

li li li Conclusion: Approximately 40% of RW HFrEF patients met criteria for the GALACTICHF trial. While findings of ongoing clinical trials may be directly generalizable to this sizable proportion of patients, future trials should examine whether the majority of patients with lower prevalence of comorbidities and rate of HF hospitalization could benefit from emerging HF treatments.

引用

页码：39 / 49

页数：11

共 50 条

[41] Empagliflozin in heart failure patients with reduced ejection fraction: a randomized clinical trial (Empire HF)
Jensen, Jesper
Omar, Massar
Kistorp, Caroline
Poulsen, Mikael Kjaer
Tuxen, Christian
Gustafsson, Ida
Kober, Lars
Gustafsson, Finn
Fosbol, Emil
Bruun, Niels Eske
Videbaek, Lars
Frederiksen, Peter Hartmund
Moller, Jacob Eifer
Schou, Morten
TRIALS, 2019, 20 (1)
[42] A Breakthrough in the Treatment of Patients With Heart Failure With Reduced Ejection Fraction: the Clinical Significance of the PARADIGM HF-Trial
Kobalava, Zh. D.
Villevalde, S. V.
Lukina, O. I.
KARDIOLOGIYA, 2017, 57 (02) : 76 - 82
[43] Revisiting ICD Therapy for Primary Prevention in Patients With Heart Failure and Reduced Ejection Fraction
Yehya, Amin
Lopez, Jose
Sauer, Andrew J.
Davis, Jonathan D.
Ibrahim, Nasrien E.
Tung, Roderick
Bozkurt, Biykem
Fonarow, Gregg C.
Al-Khatib, Sana M.
JACC-HEART FAILURE, 2025, 13 (01) : 1 - 13
[44] Sex Differences in Clinical Characteristics and Outcomes in Elderly Patients With Heart Failure and Preserved Ejection Fraction The Irbesartan in Heart Failure With Preserved Ejection Fraction (I-PRESERVE) Trial
Lam, Carolyn S. P.
Carson, Peter E.
Anand, Inder S.
Rector, Thomas S.
Kuskowski, Michael
Komajda, Michel
McKelvie, Robert S.
McMurray, John J.
Zile, Michael R.
Massie, Barry M.
Kitzman, Dalane W.
CIRCULATION-HEART FAILURE, 2012, 5 (05) : 571 - 578
[45] Four pillars of heart failure: contemporary pharmacological therapy for heart failure with reduced ejection fraction
Straw, Sam
McGinlay, Melanie
Witte, Klaus K.
OPEN HEART, 2021, 8 (01):
[46] Breakthroughs in the treatment of heart failure with mildly reduced and preserved ejection fraction
Talha, Khawaja M.
Butler, Javed
CLINICAL CARDIOLOGY, 2022, 45 : S31 - S39
[47] Management of Chronic Heart Failure with Reduced Ejection Fraction
Williamson, Brandon
Tong, Carl
JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2024, 37 (03) : 364 - 371
[48] Coronary Artery Disease and Prognosis of Heart Failure with Reduced Ejection Fraction
Vicent, Lourdes
Alvarez-Garcia, Jesus
Vazquez-Garcia, Rafael
Gonzalez-Juanatey, Jose R.
Rivera, Miguel
Segovia, Javier
Pascual-Figal, Domingo
Bover, Ramon
Worner, Fernando
Fernandez-Aviles, Francisco
Ariza-Sole, Albert
Martinez-Selles, Manuel
JOURNAL OF CLINICAL MEDICINE, 2023, 12 (08)
[49] Effects of Digoxin in Heart Failure (HF) With Reduced Ejection Fraction (EF)
Parikh, Riya R.
Patel, Khushbu R.
Pergolizzi, Joseph, V
Breve, Frank
Magnusson, Peter
CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (03)
[50] Medication dosing for heart failure with reduced ejection fraction - opportunities and challenges
Marti, Catherine N.
Fonarow, Gregg C.
Anker, Stefan D.
Yancy, Clyde
Vaduganathan, Muthiah
Greene, Stephen J.
Ahmed, Ali
Januzzi, James L.
Gheorghiade, Mihai
Filippatos, Gerasimos
Butler, Javed
EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 (03) : 286 - 296

← 1 2 3 4 5 →